Literature DB >> 2785557

Partial purification of a mast cell growth-enhancing activity and its separation from IL-3 and IL-4.

J Moeller1, L Hültner, E Schmitt, P Dörmer.   

Abstract

A growth factor acting synergistically with IL-3 on thiol-sensitive "mucosal type" bone marrow-derived mast cell lines, and therefore termed mast cell growth enhancing activity, is present in PWM stimulated spleen cell conditioned medium. Mast cell growth enhancing activity can be partially purified and completely separated from IL-3, IL-4, and IL-5, and for the most part from IL-6 and GM-CSF using strong cation exchange and Procion red affinity chromatography. Mast cell growth enhancing activity binds to Con A-Sepharose and can be digested with trypsin and chymotrypsin. It shows a Mr ranging from 37 to 43 kDa under nonreducing SDS-PAGE and a main isoelectric point ranging from 6.2 to 7.3.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2785557

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

Review 1.  Discovery and initial characterization of Th9 cells: the early years.

Authors:  Edgar Schmitt; Tobias Bopp
Journal:  Semin Immunopathol       Date:  2016-11-28       Impact factor: 9.623

2.  Schistosoma mansoni infection in mice augments the capacity for interleukin 3 (IL-3) and IL-9 production and concurrently enlarges progenitor pools for mast cells and granulocytes-macrophages.

Authors:  R M Khalil; A Luz; R Mailhammer; J Moeller; A A Mohamed; S Omran; P Dörmer; L Hültner
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

3.  Effects of FK506 and cyclosporin A on proliferation, histamine release and phenotype of murine mast cells.

Authors:  N Toyota; Y Hashimoto; S Matsuo; Y Kitamura; H Iizuka
Journal:  Arch Dermatol Res       Date:  1996-07       Impact factor: 3.017

4.  Transforming growth factor beta 1 inhibits IL-3- and IL-4-dependent mouse connective tissue-type mast cell proliferation.

Authors:  N Toyota; Y Hashimoto; S Matsuo; H Iizuka
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

5.  IL9 maps to mouse chromosome 13 and human chromosome 5.

Authors:  B A Mock; M Krall; C A Kozak; M N Nesbitt; O W McBride; J C Renauld; J Van Snick
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

Review 6.  An Update on Interleukin-9: From Its Cellular Source and Signal Transduction to Its Role in Immunopathogenesis.

Authors:  Sushmita Chakraborty; Katharina F Kubatzky; Dipendra Kumar Mitra
Journal:  Int J Mol Sci       Date:  2019-04-29       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.